摘要
目的:评价米非司酮用于足月妊娠引产时对胎盘血液供应的影响。方法:将97例妊娠38~42周具有引产指征的孕妇随机分为两组:治疗组(49例)给予口服米非司酮,每次50mg12小时1次连续2天后,阴道置米索前列醇25μg,12小时1次;对照组(48例)予静脉推注蒂洛安200mg,每日1次连续3天后,静脉点滴催产素引产。两组孕妇均在用药前及用药后36~48小时行脐动脉血流速度测定,以收缩期血流速度峰值(S)与舒张末期血流速度峰值(D)的比值(S/D)为测定参数,观察用药前及用药后36~48小时的脐血流S/D值的改变。结果:两组用药前及用药后36~48小时的脐血流S/D值比较,差异无显著性(P>0.05)。结论:米非司酮50mg12小时1次连续2天口服用于足月妊娠引产不仅效果良好,且对胎盘血流动力学无显著影响。
Objective: To evaluate the effects of mifepristone for induction of term labor on blood supply of placenta. Methods: 97 pregnant women (38~42 gestational weeks) were recruited, and randomly allocated into 2 groups, group 1 (n=49) mifepristone was given orally 50mg q12h for 2 days followed by misoprostol intravaginally (25μg q12h); group 2 (n=48), Sodium prasterone sulfate intravenous injection of 200 mg qd for 3 days followed by oxytocin intravenous infusion. Fetal umbilical artery flow velocity was determined before and 36~48 hours after treatment to observe the variation of S/D value in both groups. Results: There were no significant variations of S/D value in both groups (P>0.05) .Conclusions: Mifipristone for induction of term labor (50mg q12h for 2days) is effective, and has no significant influence on the blood supply of placenta.
出处
《中华妇产科杂志》
CAS
CSCD
北大核心
1997年第12期732-734,共3页
Chinese Journal of Obstetrics and Gynecology